Medtronic
Questions? Call our TAVR Support Team: 800-258-9220
Call our TAVR Support Team: 800-258-9220

Medtronic TAVR for women:

Treat your severe aortic stenosis†

Heart valve failure (severe aortic stenosis) has serious risks — and treating it can’t wait. Medtronic TAVR is proven for women.‡,1–3 Get help now, and imagine life in full color.

†Medtronic TAVR is indicated to treat patients who have been diagnosed with symptomatic severe aortic stenosis.
Older couple with dog
Left arrow
1
Left arrow

What symptoms10 are you experiencing?

Select all that apply.

Next

This is a required question

Please select an answer from the list above.
Left arrow
2

What is your age?


Please select an answer from the list above.
Female Medtronic TAVR patient

Sally

Medtronic TAVR patient

This is a required question

3

Have you ever been diagnosed with heart valve failure?

This is also known as symptomatic severe aortic stenosis, and it's OK if you're not sure.

This is a required question

Please select an answer from the list above.

Julia

Medtronic TAVR patient
Left arrow
4
Back arrow

Let’s take your next TAVR step, together.

Our Medtronic TAVR support team can help you find experienced heart team options in your area.

*Required fields

Medtronic will only use your data for marketing purposes related to relevant medical education. You may opt out at any time.
© Medtronic. US-CV-2600703 V1.0

Thank you for sharing!

A member of our Medtronic TAVR support team will reach out shortly to answer your questions and help you find experienced heart team options in your area.
Senior couple Medtronic TAVR patient

Thank you for sharing!

Medtronic TAVR is indicated to treat patients with symptomatic severe aortic stenosis. Talk to your doctor about testing and diagnosis. When you’re ready, we’re here to help.


Learn more about Medtronic TAVR

Senior couple Medtronic TAVR patient
Important Safety Information ⟶

Treating aortic stenosis can't wait!


Severe aortic stenosis prevents your aortic valve leaflets from opening and closing properly. Failure to seek treatment for heart valve failure is a problem that can cost women their lives.

Treating aortic stenosis graphic

Without treatment, once severe symptoms develop, the average patient survival rate at 2 years is a shockingly low 50%.4

What makes this such a pressing women’s health issue is that although proven treatments exist, such as Transcatheter Aortic Valve Replacement (TAVR) and Surgical Aortic Valve Replacement (SAVR), women are up to 35% less likely to be treated than men.5




Talk to your doctor and contact a heart team now for a simple evaluation.

Medtronic TAVR – helping women beat the odds


After a diagnosis of heart valve failure, if your doctor decides you're a candidate, Medtronic TAVR offers a promising option with distinct advantages over SAVR.◊,6 Among TAVR options, Medtronic TAVR has a unique design that produces excellent outcomes for women. It’s not just any heart valve, it’s proven for women.†,1-3

Info computer icon
A heart valve failure diagnsois is both cause for urgency and a lot to process. We can help. The Medtronic TAVR Support Team is here to answer your questions and can help you connect with a heart team of your choosing.

Call 800-258-9220 Call 800-258-9220
Female Medtronic TAVR patient with doctor

Discover Medtronic TAVR - proven for women


In a recent TAVR clinical trial focusing on patients with small heart valves, predominantly women, the Medtronic Evolut™ TAVR valve delivered superior valve performance‡ for women compared to the Edwards Lifesciences SAPIEN TAVR™* valve, but there were no differences in safety outcomes. The SMART trial, as it’s commonly known, revealed the following important findings at one year:

better valve function icon

5X

better valve function‡

Women experienced 5x less valve dysfunction with the Medtronic TAVR compared to the Edwards SAPIEN TAVR.1

better blood flow icon

10X

better blood flow

Medtronic TAVR is 10x better at restoring normal blood flow compared to Edwards TAVR.1

quality of life icon

Better

quality of life#

Medtronic TAVR delivered significantly improved quality of life compared to those treated with the Edwards TAVR.1

TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and need for permanent pacemaker.

What is the TAVR procedure?


Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace the aortic valve in patients with severe aortic stenosis. TAVR is less invasive than open-heart surgery (SAVR), and the procedure typically takes less than one hour. Your heart team will determine if you should have a mild sedative or general anesthesia.


While TAVR procedures are minimally invasive, they still carry risk. Talk to your doctor about the risks and benefits of a TAVR procedure.
I can walk, I can dance, I can cook, drive, basically do anything I want to do! I do it all myself and I love it. I’m grateful I have my health and strength back.

Darian | Medtronic TAVR patient
Senior female Medtronic TAVR patient
Benefits may vary, for some patients, the Medtronic TAVR procedure risks may outweigh the benefits. Please talk to your doctor to decide whether this therapy is right for you.
I’m amazed because I can do anything I want to do. I’m living a new life, and I really recommend fighting for it.

Julia | Medtronic TAVR patient
Julia | Medtronic TAVR patient
Benefits may vary, for some patients, the Medtronic TAVR procedure risks may outweigh the benefits. Please talk to your doctor to decide whether this therapy is right for you.

Learn from the experiences of women who've faced heart valve failure and made the SMART choice.

Patient story: Darian

Patient story: Darian

Patient story: Julia

Patient story: Julia

Know the Difference: See if the Medtronic TAVR valve is right for you.


Any heart valve failure diagnosis is too serious to delay seeking medical advice. Talk with the Medtronic TAVR Support Team to learn more about your severe aortic stenosis§ journey, get answers to your questions, and connect with a heart team of your choosing near you.
Frequently asked questions about Medtronic TAVR
FAQs
Call to learn more about Medtronic TAVR
Talk to the Medtronic TAVR Support Team
800-258-9220 Call to learn more about Medtronic TAVR
Talk to the Medtronic TAVR Support Team
800-258-9220
Take the quiz
See if Medtronic TAVR is right for you

† Based on the 1 year follow-up results from the SMART clinical trial which showed differences in valve performance‡ for Evolut™ compared to SAPIEN™* and no differences in safety outcomes. SMART primarily studied small annulus patients, predominantly women1. Additional clinical trials on women, regardless of their annulus size, have shown comparable mortality rates in women and men treated with TAVR2 and lower mortality rates for women treated with TAVR compared to women treated with surgical valve replacement3 at 1 year after the procedure.​

‡ Valve performance is as defined as freedom from bioprosthetic valve dysfunction (BVD) through 12 months. BVD is defined as a composite including any of the following: hemodynamic structural valve dysfunction (mean gradient ≥ 20 mmHg), non-structural valve dysfunction (severe prothesis-patient mismatch or ≥ moderate aortic regurgitation), clinical thrombosis, endocarditis, and aortic valve reintervention.

§ Medtronic TAVR is indicated to treat patients who have been diagnosed with symptomatic severe aortic stenosis.

◊ Distinct advantages over SAVR include better blood flow from improved hemodynamics.

¶ Better blood flow, or “near-normal transvalvular flow” means that your new heart is operating well and the gradient across your valve is < 20 mmHg.

# Quality of life was based on results from the Kansas City Cardiomyopathy Questionnaire.

TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and need for permanent pacemaker.


  1. Tchétché D, Mehran R, Blackman DJ, et al. Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial. JAMA Cardiol. Published online October 09, 2024.
  2. Forrest, J.K., et al., Transcatheter Aortic Valve Replacement in Women Versus Men (from the US CoreValve Trials). Am J Cardiol, 2016. 118(3): p. 396-402.
  3. Skelding, K.A., et al., Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial). Am J Cardiol, 2016. 118(4): p. 560-6.
  4. Ross J Jr, Braunwald E. Aortic stenosis. Circulation. July 1968;38(1 Suppl):61-67. 
  5. Rice CT, Barnett S, O'Connell SP, et al. Impact of gender, ethnicity and social deprivation on access to surgical or transcatheter aortic valve replacement in aortic stenosis: a retrospective database study in England. Open Heart. September 2023;10(2):e002373.
  6. Forrest, J.K., Yakubov, S.J., Deeb. M., et al. 5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis. J Am Coll Cardiol. 2025 April, 85 (15) 1523-1532.
  7. Tribouilloy C, Bohbot Y, Rusinaru D, Belkhir K, et al. Excess Mortality and Undertreatment of Women With Severe Aortic Stenosis. J Am Heart Assoc. 2021 Jan 5;10(1):e018816. 
  8. Williams M, Kodali SK, Hahn RT, et al. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol. April 22, 2014;63(15):1522–1528.
  9. Medtronic Data on File.
  10. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. February 2, 2021;143(5):e35-e71.